Transforming Chronic Lymphocytic Leukemia Care: Real-world Patient and Provider Perspectives

Overview

Intended Audience: Hematology/Oncology teams (physicians, PAs, NPs, nurses) and patients/caregivers with CLL

Advances in the treatment and management of chronic lymphocytic leukemia (CLL) are transforming clinical outcomes and improving quality of life for patients. During this live webinar, expert CLL faculty will discuss the results from our survey of patients and providers evaluating the current state of CLL care. Faculty will provide practical tips and resources to guide interprofessional teams in educating patients on their therapeutic options and follow-up assessments, supporting patients in sharing their experiences, goals, and preferences, and engaging patients in shared decision-making.

Learning Objectives

Address gaps in patient-provider knowledge and perceptions about treatment options for chronic lymphocytic leukemia (CLL)
Implement resources to engage patients in shared decision-making about CLL treatment
Foster collaborative discussions between patients and providers on guidelines and recent clinical evidence to guide personalized treatment planning for CLL

Agenda

Benchmarks in CLL Care: Real-world Patient and Provider Perspectives
SDM as a Path to Evidence-Based CLL Treatment
Cultivating Shared Understanding and Treatment Goals With Patients
Communicating the Risks and Benefits of CLL Treatment Options
Current Guidelines, Recent Evidence, and Best Practices for CLL Management
Practical Strategies to Improve Patient-Centered CLL Care

Faculty

Matthew S Davids, MD, MMSc

Course Director and Speaker

Associate Professor of Medicine, Harvard Medical School
Director of Clinical Research, Division of Lymphoma
Attending Physician, Department of Medical Oncology
Dana-Farber Cancer Institute
Boston, MA

Lori A Leslie, MD

Speaker

Attending Physician, Lymphoma Division
Director, Indolent Lymphoma and CLL Research Program
John Theurer Cancer Center
Co-Medical Director, Mountainside Medical Center Cancer Program
Assistant Professor of Medicine
Hackensack Meridian School of Medicine
Hackensack, NJ

Ryan J Atkinson, PharmD, MBA

Moderator

Senior Director of Specialty Pharmacy Strategy
Maxor National Pharmacy Services, LLC
Indianapolis, IN

Joyce M Knestrick, PhD, CRNP, FAANP

Planner

Visiting Professor
George Washington University
Family Nurse Practitioner
Wheeling Health Right
Wheeling, WV

Kristi Kay Orbaugh, RN, MSN, RNP, AOCN

Planner

Adult Nurse Practitioner
Community Hospital Oncology Physicians
Indianapolis, IN

Henry A Solomon, MD, FACP, FACC

Peer Reviewer

Cardiologist and Internal Medicine Physician
New York, NY

CE Details & Instructions

Joint Accreditation Statement

In support of improving patient care, PRIME® is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Interprofessional Teams

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

Physician Credit Designation Statement

PRIME® designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Physician Assistant Accreditation Statement

PRIME® has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioner Accreditation Statement

Nurse Practitioner Logo PRIME Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This activity is approved for 1.0 contact hour (which includes 0 hour of pharmacology).

Pharmacist Accreditation Statement

This Application-based activity has been approved for 1.0 contact hour (0.1 CEUs) by PRIME® for pharmacists. The Universal Activity Number for this activity is JA0007144-0000-21-207-L01-P . Pharmacy CE credits can be submitted to the NABP upon successful completion of the activity by providing your NABP ID & DOB, which must be submitted within 60 days of completion. Pharmacists with questions can contact NABP customer service ([email protected]).

Nurse Accreditation Statement

PRIME® designates this activity for 1.0 contact hour.

Obtaining CE Credit

Register using the online form
Complete the pre-registration survey
Attend the live program in its entirety
Complete an online evaluation and post-test
Download and/or print a certificate of completion and/or submit CE credits electronically

Instructions to access CME/CE credit options will be provided at the end of the program.

Method of Participation

This live CME/CE activity requires attendance of the participant during the entire program and completion of learner assessment tools. The learner will then receive instructions on how to download and/or print a certificate of completion and/or submit CE credits electronically.

Device Requirements

Hardware: an Internet-enabled computer, smartphone, tablet, or mobile device with audio capabilities and Internet connectivity
Software: the installation of software such as GoToWebinar may be required

Faculty Disclosures

*PRIME® has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity.

The following individuals have identified relevant financial relationships with commercial interests to disclose:

Matthew S Davids, MD, MMSc (Course Director, Speaker)

Advisory Board or Panel – AbbVie, Adaptive Biotechnologies, Ascentage Pharma, AstraZeneca, BeiGene, Bristol-Myers Squibb, Eli Lilly and Company, Genentech, Janssen, Pharmacyclics, Takeda
Consultant – AbbVie, Adaptive Biotechnologies, AstraZeneca, BeiGene, Genentech, Janssen, Merck, Pharmacyclics, Zentalis
Grants / Research Support – Ascentage Pharma, AstraZeneca, Genentech, MEI Pharma, Novartis, Pharmacyclics, Takeda
Other Financial or Material Support (royalties, patents, etc.) – Research to Practice
Lori A Leslie, MD (Speaker)

Advisory Board or Panel – AbbVie, AstraZeneca, BeiGene, Celgene/Bristol Myers Squibb, Epizyme, Janssen, Kite/Gilead Sciences, Pharmacyclics, Seagen, TG Therapeutics
Consultant – AbbVie, AstraZeneca, BeiGene, Celgene/Bristol Myers Squibb, Epizyme, Janssen, Kite/Gilead Sciences, Merck, Pharmacyclics, Seagen, TG Therapeutics
Speakers Bureau or other Promotional Education – AstraZeneca, BeiGene, Celgene/Bristol Myers Squibb, Epizyme, Janssen, Karyopharm Therapeutics, Kite/Gilead Sciences, Pharmacyclics, Seagen, TG Therapeutics
Kristi Kay Orbaugh, RN, MSN, RNP, AOCN (Planner)

Speakers Bureau or other Promotional Education – Astellas, AstraZeneca, Bristol-Myers Squibb, Coherus, DSI, Dova, Eli Lilly and Company, Gilead Sciences, Morphosys, Pfizer

The following individuals have no relevant financial relationships with commercial interests to disclose:

Ryan J Atkinson, PharmD, MBA (Moderator)
Henry A Solomon, MD, FACP, FACC (Reviewer)
Joyce M Knestrick, PhD, CRNP, FAANP (Planner)

All PRIME® staff participating in planning and content development have no relevant financial relationships with commercial interests to disclose.

Funding Disclosure

This activity is provided by PRIME Education. There is no fee to participate. This activity is supported by educational grants from Adaptive Biotechnologies, Genentech, and Pharmacyclics, an AbbVie Company.

Accessibility Statement

At PRIME, we are committed to ensuring that individuals with disabilities can access all of the content offered by PRIME through our website and other properties. If you are having trouble accessing primeinc.org, please email [email protected] for assistance. Please put "ADA Inquiry" in the subject line of your email.

Summary


Cost:	FREE


Credit:	No Credit Offered

Create Account